Elan Corporation, plc

  ELN website

ELN   /  Message Board  /  Read Message

 
BOARD

GROUPS

NEWS
 








allspades
x
bkjh448
x
expobear
x
f45bethere
x
fast money
x
field-this
x
Gimundo
x
goodtoreadthis
x
heylucyitsricky
x
huntsmann_ie
x
jayelliii
x
kcchris
x
kriderc
x
masterlongevity
x
mewag50
x
ncc53
x
nphillycuts&fades
x
opRTuner
x
peadar_og
x
ridge303
x
RocketRoj
x
sak77346
x
Sam I Am
x
schull
x
sgt.koris
x
Sly_Yook
x
sly44
x
splaylaywahtheepi
x
stardust0102
x
sunylouie7
x
SuperMan
x
tecumseh2020
x
turtlewinsrace
x
uhhuh
x
wharfrat1940
x
zzzster
x


 
Loading...
 
 





My ELN Ignore List


Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message board, top of board
Msg  502960 of 534048  at  6/4/2012 9:24:56 AM  by

Sam I Am


Bristol-Myers Squibb's anti-PD-1 immunotherapy generated the most ASCO buzz and has blockbuster potential across several solid tumors



 
     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0  |  Views: 64
Previous Message  Next Message   Post Message   Post a Reply return to message board, top of board


About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help  •  Advertise
Not a member yet? What are you waiting for? Join Now
Want to contribute? Support InvestorVillage by donating
© 2003-2013 Investorvillage.com. All rights reserved. User Agreement 		   
Financial Market Data provided by
.


Loading...